PMID- 22923493 OWN - NLM STAT- MEDLINE DCOM- 20130117 LR - 20221207 IS - 1528-0020 (Electronic) IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 120 IP - 15 DP - 2012 Oct 11 TI - HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk. PG - 3039-47 LID - 10.1182/blood-2012-01-404723 [doi] AB - The human leukocyte antigen (HLA) genes are candidate genetic susceptibility loci for childhood acute lymphoblastic leukemia (ALL). We examined the effect of HLA-DP genetic variation on risk and evaluated its potential interaction with 4 proxies for early immune modulation, including measures of infectious exposures in infancy (presence of older siblings, daycare attendance, ear infections) and breastfeeding. A total of 585 ALL cases and 848 controls were genotyped at the HLA-DPA1 and DPB1 loci. Because of potential heterogeneity in effect by race/ethnicity, we included only non-Hispanic white (47%) and Hispanic (53%) children and considered these 2 groups separately in the analysis. Logistic regression analyses showed an increased risk of ALL associated with HLA-DPB1*01:01 (odds ratio [OR] = 1.43, 95% CI, 1.01-2.04) with no heterogeneity by Hispanic ethnicity (P = .969). Analyses of DPB1 supertypes showed a marked childhood ALL association with DP1, particularly for high-hyperdiploid ALL (OR = 1.83; 95% CI, 1.20-2.78). Evidence of interaction was found between DP1 and older sibling (P = .036), and between DP1 and breastfeeding (P = .094), with both showing statistically significant DP1 associations within the lower exposure categories only. These findings support an immune mechanism in the etiology of childhood ALL involving the HLA-DPB1 gene in the context of an insufficiently modulated immune system. FAU - Urayama, Kevin Y AU - Urayama KY AD - School of Public Health, University of California, Berkeley, CA 94704, USA. kurayama@luke.or.jp FAU - Chokkalingam, Anand P AU - Chokkalingam AP FAU - Metayer, Catherine AU - Metayer C FAU - Ma, Xiaomei AU - Ma X FAU - Selvin, Steve AU - Selvin S FAU - Barcellos, Lisa F AU - Barcellos LF FAU - Wiemels, Joseph L AU - Wiemels JL FAU - Wiencke, John K AU - Wiencke JK FAU - Taylor, Malcolm AU - Taylor M FAU - Brennan, Paul AU - Brennan P FAU - Dahl, Gary V AU - Dahl GV FAU - Moonsamy, Priscilla AU - Moonsamy P FAU - Erlich, Henry A AU - Erlich HA FAU - Trachtenberg, Elizabeth AU - Trachtenberg E FAU - Buffler, Patricia A AU - Buffler PA LA - eng GR - R03 CA125823/CA/NCI NIH HHS/United States GR - P42ES0470518/ES/NIEHS NIH HHS/United States GR - R01ES09137/ES/NIEHS NIH HHS/United States GR - R01 ES009137/ES/NIEHS NIH HHS/United States GR - R03CA125823/CA/NCI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Multicenter Study PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120824 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (HLA-DP alpha-Chains) RN - 0 (HLA-DP beta-Chains) RN - 0 (HLA-DPA1 antigen) RN - 0 (HLA-DPB1 antigen) RN - 0 (Immunologic Factors) SB - IM MH - Adolescent MH - Adult MH - Case-Control Studies MH - Child MH - Child, Preschool MH - Female MH - Genetic Predisposition to Disease MH - Genetic Variation/*genetics MH - Genotype MH - HLA-DP alpha-Chains/*genetics MH - HLA-DP beta-Chains/*genetics MH - Hispanic or Latino/genetics MH - Humans MH - *Immunologic Factors MH - Infant MH - Male MH - Precursor Cell Lymphoblastic Leukemia-Lymphoma/ethnology/*etiology MH - Prognosis MH - Risk Factors MH - White People/genetics MH - Young Adult PMC - PMC3471514 EDAT- 2012/08/28 06:00 MHDA- 2013/01/18 06:00 PMCR- 2013/10/11 CRDT- 2012/08/28 06:00 PHST- 2012/08/28 06:00 [entrez] PHST- 2012/08/28 06:00 [pubmed] PHST- 2013/01/18 06:00 [medline] PHST- 2013/10/11 00:00 [pmc-release] AID - S0006-4971(20)46308-6 [pii] AID - 2012/404723 [pii] AID - 10.1182/blood-2012-01-404723 [doi] PST - ppublish SO - Blood. 2012 Oct 11;120(15):3039-47. doi: 10.1182/blood-2012-01-404723. Epub 2012 Aug 24.